NOC vs PPCB · P/E 17, rev $41.95B vs P/E 0.0, $3.9M cap
Northrop Grumman Corporation (NOC) versus Propanc Biopharma, Inc. Common Stock (PPCB) — a side-by-side from cached financials, not a winner call.
Northrop Grumman Corporation (NOC) is a aerospace & defense company listed on NYSE.
Propanc Biopharma, Inc. Common Stock (PPCB) is a biotechnology company listed on NASDAQ.
Latest reported NOC revenue for 2025-12-31 was $41.95B. Net income was $4.18B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. NOC currently screens at market cap $78.14B and trailing P/E 17.2.
PPCB does not have a complete income-statement cache yet.
NOC currently screens at market cap $78.14B and trailing P/E 17.2. PPCB currently screens at market cap $3.9M and trailing P/E 0.0.
Not investment advice. Open the NOC and PPCB stock pages for the full models.
Not investment advice.